GLP-1 Diarrhea and Loose Stools: Why It Happens, How Long It Lasts, and What Helps

Most people starting semaglutide or tirzepatide brace for nausea. Fewer expect to spend the Saturday after their injection mapping every bathroom between home and the grocery store.

Diarrhea is the second most reported digestive side effect in the big GLP-1 obesity trials, behind nausea and ahead of vomiting. It also confuses people, because these medicines are known for slowing the gut down. Both things are true at once, and the reasons explain most of what people can do about it.

This article covers how often GLP-1 diarrhea happens, why it happens, how long a typical bout lasts, which foods and products tend to set it off, how to replace fluid properly, and the signs that mean a call to a clinician rather than another day of waiting.

How common is diarrhea on semaglutide and tirzepatide?

Roughly one person in four or five

Diarrhea affects roughly a fifth to a third of people in the major GLP-1 obesity trials, depending on the drug and dose. Wilding and colleagues reported diarrhea in 31.5 percent of STEP 1 participants on semaglutide 2.4 mg versus 15.9 percent on placebo (New England Journal of Medicine, 2021). The placebo figure is a useful reminder that loose stools are common in any large group of adults over a year and a half, so only part of the 31.5 percent is the drug.

Tirzepatide shows a similar picture with a mild dose gradient. In SURMOUNT-1, Jastreboff and colleagues reported diarrhea in 18.7 percent of participants at 5 mg, 21.2 percent at 10 mg, and 23.0 percent at 15 mg, against 7.3 percent on placebo (New England Journal of Medicine, 2022). The jump from placebo to the lowest dose is much larger than the jump between doses, which suggests that starting the drug at all, and each escalation step, matter more than the final maintenance number.

Severity in the trials was mostly mild to moderate. Few people stopped treatment because of diarrhea alone. In STEP 1, 4.5 percent of semaglutide participants discontinued because of any gastrointestinal event, compared with 0.8 percent on placebo.

Why can a medicine that slows digestion cause diarrhea?

The stomach and the bowel respond differently

A GLP-1 medicine can cause diarrhea because its slowing effect is strongest in the stomach, while its effects further down the gut on motility, fluid secretion, and bile acids vary from person to person. Gastric emptying slows clearly in the first weeks of treatment and partly adapts over time, a pattern seen in scintigraphy studies of liraglutide and semaglutide. The small intestine and colon carry GLP-1 receptors too, and the net effect there is less predictable.

Bile acids are one likely contributor. GLP-1 medicines change gallbladder contraction and bile flow, which is part of why gallstone risk rises during rapid weight loss. Bile acids that reach the colon in larger amounts pull water into the bowel and speed transit, the same mechanism behind bile acid diarrhea in people who have had their gallbladder removed. Researchers have proposed this route for GLP-1 related diarrhea, though it has not been confirmed as the main driver.

Meal size and fat content add a mechanical piece. A large, fatty meal sitting in a slowed stomach can empty in bursts, and a load of fat arriving faster than digestion can handle tends to loosen stools. Many people notice that diarrhea follows the one meal where appetite briefly returned and they ate as they used to. Tirzepatide adds a second hormone, GIP, which has its own effects on fat handling, but the human data do not yet show that GIP changes diarrhea risk in a meaningful way.

How long does GLP-1 diarrhea last?

Short bouts, clustered around dose steps

A single bout of GLP-1 diarrhea usually lasts a few days. Wharton and colleagues pooled the STEP 1, 2, and 3 trials and found a median duration of about 3 days per diarrhea event on semaglutide 2.4 mg, compared with about 8 days for nausea, 2 days for vomiting, and around 47 days for constipation (Diabetes, Obesity and Metabolism, 2022). Constipation is the slow, lingering side effect. Diarrhea comes and goes.

The timing follows the dose schedule. Most new gastrointestinal events in the STEP and SURMOUNT programs appeared during the escalation period, in the days after starting or stepping up, and became less frequent once participants reached a stable maintenance dose. A person on a standard four-weekly escalation can therefore see a rhythm: a looser few days after each step, then settling, then another step. That rhythm is a useful sign that the medicine, rather than an infection, is the likely cause.

Which foods and products make GLP-1 diarrhea worse?

The protein bar problem

Sugar alcohols, lactose, and large high-fat meals are the most common dietary triggers that make GLP-1 diarrhea worse. Many people on a GLP-1 lean on protein bars, low-sugar snacks, and shakes to hit protein targets with a small appetite. Those products often contain sorbitol, maltitol, or xylitol, which are poorly absorbed and pull water into the bowel. Sorbitol can loosen stools at around 10 grams in a sitting for many adults, and a single "sugar-free" bar or a handful of sugar-free sweets can get close to that.

Erythritol is far better tolerated because most of it is absorbed in the small intestine and leaves in urine, so it rarely reaches the colon in large amounts. Allulose sits somewhere in between. Checking the ingredient list for words ending in "-itol" is one of the quickest ways to find a hidden trigger.

Lactose is the other common one. Whey concentrate shakes, milk-based protein drinks, and large servings of cottage cheese or Greek yogurt add lactose that adults with low lactase activity cannot fully digest. Whey isolate and lactose-free milk carry far less. Coffee, alcohol, and very spicy food speed colonic transit in some people, and metformin, which is often taken alongside a GLP-1, has diarrhea as its own most common side effect. Our metformin article covers that combination in detail.

Can GLP-1 constipation turn into diarrhea?

Overflow looks like the opposite problem

GLP-1 constipation can turn into overflow diarrhea, where liquid stool from higher in the bowel leaks around a hard, impacted mass lower down. Overflow tends to look like frequent, small, watery stools after several days of straining or no real bowel movement, often with bloating, cramping, or a feeling that the bowel never fully empties. Older adults and people on opioids or iron supplements are more prone to it.

Telling the two apart matters, because the fixes run in opposite directions. Loperamide and other anti-diarrheal products can make overflow worse by slowing the bowel further. Anyone who has gone from days of constipation to sudden watery leakage on a GLP-1 should check with a clinician before reaching for an anti-diarrheal. The constipation article on this site covers fiber, fluid, and osmotic laxative options in more depth.

What is the best way to rehydrate after diarrhea on a GLP-1?

Sodium plus glucose, in small sips

The best way to rehydrate after diarrhea on a GLP-1 is an oral rehydration solution taken in small, frequent sips. Oral rehydration works because the small intestine absorbs sodium and glucose together through a shared transporter, and water follows. The World Health Organization's low-osmolarity formula contains 75 mmol of sodium and 75 mmol of glucose per litre, a balance chosen to maximise absorption without drawing extra water into the gut.

Plain water replaces volume but not sodium. Sports drinks usually carry about a quarter of the sodium in ORS and several times the sugar, and apple juice is almost pure sugar with very little sodium, which can make loose stools worse. For a mild bout, water plus salty food such as broth or crackers is often enough. For several watery stools in a day, a pharmacy rehydration sachet is the better tool.

Hydration carries more weight on a GLP-1 than it might otherwise, because thirst is often blunted and total intake is already low. The Wegovy and Zepbound US labels both list acute kidney injury as a warning, mainly in people who became dehydrated through vomiting or diarrhea. A practical cue is urine colour: pale straw is the target, and dark urine or very little urine after a day of diarrhea is a reason to step up fluids and call the prescriber.

What practical steps reduce diarrhea on a GLP-1 protocol?

Small changes matched to each cause

The steps that reduce diarrhea on a GLP-1 protocol mostly involve meal size, ingredient labels, and fluid planning. None has been tested in a GLP-1 trial, but each addresses a known mechanism.

Does GLP-1 diarrhea affect other medicines?

Fast transit, less absorption

GLP-1 diarrhea can affect other medicines, because fast transit and fluid loss reduce how much of an oral drug the gut absorbs. The combined oral contraceptive pill is the best-known example, and standard pill guidance already treats severe diarrhea as a possible missed dose. Tirzepatide's US label adds its own advice: people on oral contraceptives should use a non-oral method or a backup barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.

Levothyroxine, some anti-seizure drugs, and lithium are other medicines where absorption or fluid status matters, and diuretics or blood pressure tablets can tip a dehydrated person toward dizziness or kidney strain. A pharmacist can review a regular medicine list and flag which ones need extra care during a week of diarrhea.

Could a lower dose GLP-1 protocol mean less diarrhea?

A modest gradient, not yet tested at microdoses

A lower dose GLP-1 protocol may mean less diarrhea, but the evidence is indirect. SURMOUNT-1 showed a gradient from 18.7 percent at 5 mg tirzepatide to 23.0 percent at 15 mg, and the semaglutide phase 2 dose-ranging trial by O'Neil and colleagues (Lancet, 2018) found gastrointestinal events increased with dose. Slower escalation is already the standard tool prescribers use when GI side effects are a problem, and labels allow a dose step to be delayed for that reason.

The gradient is shallow, though. The biggest jump in diarrhea rates sits between placebo and the first active dose, not between doses, so a smaller dose should not be expected to remove the side effect. No trial has measured diarrhea under microdose GLP-1 protocols, and dose decisions should stay with a prescriber rather than being adjusted alone after a bad week.

When does diarrhea on a GLP-1 need medical attention?

Signs that point beyond the medicine

Diarrhea on a GLP-1 needs medical attention when it comes with blood or black stools, fever, severe or constant abdominal pain, signs of dehydration, or when it lasts more than a few days without easing. Dizziness on standing, very dark urine, very little urine, or confusion suggest significant fluid loss. Severe upper abdominal pain that spreads to the back, with or without vomiting, needs urgent assessment because GLP-1 labels list pancreatitis and gallbladder disease as warnings.

Diarrhea that starts during or after a course of antibiotics raises the possibility of Clostridioides difficile infection, which needs testing rather than home care. Diarrhea in someone with diabetes who is also taking insulin or a sulfonylurea can disrupt glucose control in either direction. In each of these situations, the GLP-1 may be one factor, but it should not be assumed to be the whole story.

Frequently Asked Questions